Upadacitinib for treating moderate rheumatoid arthritis

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers (PDF 617 KB)

  Published:

  10 November 2021

• Appraisal consultation 1 committee papers (PDF 6.28 MB)

  Published:

  10 November 2021

• Appraisal consultation 2 committee papers (PDF 1.6 MB)

  Published:

  10 November 2021